Quinones from Rubia manjith and their antitumor activity.
1/5 보강
Rubia plants, well-recognized as medicinal resources, are characterized by diverse phytoconstituents and a broad spectrum of biological activities, and have traditionally been employed in managing var
APA
Xu YF, Wang YJ, et al. (2026). Quinones from Rubia manjith and their antitumor activity.. Fitoterapia, 189, 107097. https://doi.org/10.1016/j.fitote.2026.107097
MLA
Xu YF, et al.. "Quinones from Rubia manjith and their antitumor activity.." Fitoterapia, vol. 189, 2026, pp. 107097.
PMID
41565120 ↗
Abstract 한글 요약
Rubia plants, well-recognized as medicinal resources, are characterized by diverse phytoconstituents and a broad spectrum of biological activities, and have traditionally been employed in managing various diseases. R. manjith, a representative species of the genus Rubia enriched with quinone derivatives, has long been used in traditional Chinese medicine for the treatment of hematemesis, hematuria, inflammation, ulcers, and dermatological disorders. However, up to now, no research on the chemical components of this plant has been carried out. The present study focuses on the quinone constituents of R. manjith with the aim of identifying potential anti-tumor agents. From the roots and rhizomes of R. manjith, four previously undescribed anthraquinones (1-4), together with thirty-one known quinones (5-35), were successfully isolated and identified. Their cytotoxic activities were assessed against several colorectal cancer cell lines, among which 6 exhibited pronounced antiproliferative effects. Furthermore, network pharmacology analysis in combined with molecular docking was employed to elucidate the potential mechanisms underlying the anti-tumor activity of 6.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.